Targeting NMDA Receptor Complex in Management of Epilepsy

<i>N</i>-methyl-D-aspartate receptors (NMDARs) are widely distributed in the central nervous system (CNS) and play critical roles in neuronal excitability in the CNS. Both clinical and preclinical studies have revealed that the abnormal expression or function of these receptors can under...

Full description

Bibliographic Details
Main Authors: Shravan Sivakumar, Mehdi Ghasemi, Steven C. Schachter
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/10/1297
_version_ 1797470456192696320
author Shravan Sivakumar
Mehdi Ghasemi
Steven C. Schachter
author_facet Shravan Sivakumar
Mehdi Ghasemi
Steven C. Schachter
author_sort Shravan Sivakumar
collection DOAJ
description <i>N</i>-methyl-D-aspartate receptors (NMDARs) are widely distributed in the central nervous system (CNS) and play critical roles in neuronal excitability in the CNS. Both clinical and preclinical studies have revealed that the abnormal expression or function of these receptors can underlie the pathophysiology of seizure disorders and epilepsy. Accordingly, NMDAR modulators have been shown to exert anticonvulsive effects in various preclinical models of seizures, as well as in patients with epilepsy. In this review, we provide an update on the pathologic role of NMDARs in epilepsy and an overview of the NMDAR antagonists that have been evaluated as anticonvulsive agents in clinical studies, as well as in preclinical seizure models.
first_indexed 2024-03-09T19:36:30Z
format Article
id doaj.art-4e956cdbc97844a587c3252405e57bf7
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T19:36:30Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-4e956cdbc97844a587c3252405e57bf72023-11-24T01:52:52ZengMDPI AGPharmaceuticals1424-82472022-10-011510129710.3390/ph15101297Targeting NMDA Receptor Complex in Management of EpilepsyShravan Sivakumar0Mehdi Ghasemi1Steven C. Schachter2Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USADepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USADepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA<i>N</i>-methyl-D-aspartate receptors (NMDARs) are widely distributed in the central nervous system (CNS) and play critical roles in neuronal excitability in the CNS. Both clinical and preclinical studies have revealed that the abnormal expression or function of these receptors can underlie the pathophysiology of seizure disorders and epilepsy. Accordingly, NMDAR modulators have been shown to exert anticonvulsive effects in various preclinical models of seizures, as well as in patients with epilepsy. In this review, we provide an update on the pathologic role of NMDARs in epilepsy and an overview of the NMDAR antagonists that have been evaluated as anticonvulsive agents in clinical studies, as well as in preclinical seizure models.https://www.mdpi.com/1424-8247/15/10/1297<i>N</i>-methyl-D-aspartate (NMDA) receptorseizureepilepsyNMDA receptor antagonistclinical trial
spellingShingle Shravan Sivakumar
Mehdi Ghasemi
Steven C. Schachter
Targeting NMDA Receptor Complex in Management of Epilepsy
Pharmaceuticals
<i>N</i>-methyl-D-aspartate (NMDA) receptor
seizure
epilepsy
NMDA receptor antagonist
clinical trial
title Targeting NMDA Receptor Complex in Management of Epilepsy
title_full Targeting NMDA Receptor Complex in Management of Epilepsy
title_fullStr Targeting NMDA Receptor Complex in Management of Epilepsy
title_full_unstemmed Targeting NMDA Receptor Complex in Management of Epilepsy
title_short Targeting NMDA Receptor Complex in Management of Epilepsy
title_sort targeting nmda receptor complex in management of epilepsy
topic <i>N</i>-methyl-D-aspartate (NMDA) receptor
seizure
epilepsy
NMDA receptor antagonist
clinical trial
url https://www.mdpi.com/1424-8247/15/10/1297
work_keys_str_mv AT shravansivakumar targetingnmdareceptorcomplexinmanagementofepilepsy
AT mehdighasemi targetingnmdareceptorcomplexinmanagementofepilepsy
AT stevencschachter targetingnmdareceptorcomplexinmanagementofepilepsy